None listed
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Salbutamol: Eligible individuals will receive 400 micrograms of inhaled sulbutamol after the initial oscillometry to assess the changes after the salbuta
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: i. No prior history of respiratory disease and non smoker
Exclusion criteria
Exclusion criteria: 1. Recent respiratory infection (within 4 weeks). ii. Known cardiac disease or uncontrolled systemic illness. iii.No prior history of respiratory disease (asthma, COPD, bronchiectasis, ILD, pulmonary tuberculosis, etc.). iv. Never-smoker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome variables will be whole-breath resistance at 5 Hz (R5), whole-breath reactance at 5 Hz (X5), frequency dependence of resistance (R5 20), resonant frequency (Fres), and reactance area (AX), defined as the integral of reactance between 5 Hz and Fres.Timepoint: The outcome variables will be whole-breath resistance at 5 Hz (R5), whole-breath reactance at 5 Hz (X5), frequency dependence of resistance (R5 20), resonant frequency (Fres), and reactance area (AX), defined as the integral of reactance between 5 Hz and Fres. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the variability of oscillometry parameters across different age groups andbetween genders following administration of inhaled bronchodilator. Timepoint: After bronchodilator | — |
Countries
India
Contacts
Public ContactSajal De
All India Institute of Medical Sciences Raaipur
Outcome results
None listed